| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
|
Stahl, Maximilian
|
|
|
7 |
12 |
p. 2709-2714
|
artikel
|
| 2 |
Autologous transplant and second malignancies in MM
|
Pasvolsky, Oren
|
|
|
7 |
12 |
p. 2731-2732
|
artikel
|
| 3 |
A wholesale approach to disarm multiple myeloma
|
Cenci, Simone
|
|
|
7 |
12 |
p. 2938-2939
|
artikel
|
| 4 |
BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia
|
Olesinski, Elyse A.
|
|
|
7 |
12 |
p. 2917-2923
|
artikel
|
| 5 |
Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival
|
Gangat, Naseema
|
|
|
7 |
12 |
p. 2694-2698
|
artikel
|
| 6 |
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
|
Bonfiglio, Silvia
|
|
|
7 |
12 |
p. 2794-2806
|
artikel
|
| 7 |
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
|
Akahoshi, Yu
|
|
|
7 |
12 |
p. 2699-2708
|
artikel
|
| 8 |
Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function
|
Leung, Isabel
|
|
|
7 |
12 |
p. 2718-2730
|
artikel
|
| 9 |
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study
|
Stojkov, Igor
|
|
|
7 |
12 |
p. 2772-2783
|
artikel
|
| 10 |
Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects
|
Li, Shirong
|
|
|
7 |
12 |
p. 2926-2937
|
artikel
|
| 11 |
Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma
|
Takiar, Radhika
|
|
|
7 |
12 |
p. 2912-2916
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
7 |
12 |
p. i
|
artikel
|
| 13 |
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma
|
Roddie, Claire
|
|
|
7 |
12 |
p. 2872-2883
|
artikel
|
| 14 |
Fabrizio VA, Boelens JJ, Mauguen A, et al. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022;6(7):1961-1968.
|
|
|
|
7 |
12 |
p. 2924
|
artikel
|
| 15 |
Front Matter
|
|
|
|
7 |
12 |
p. ii
|
artikel
|
| 16 |
Further analysis of incidence of multiple myeloma among atomic-bomb survivors, 1950 to 1994
|
Yoshida, Noriaki
|
|
|
7 |
12 |
p. 2807-2810
|
artikel
|
| 17 |
HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
|
Lai, Tzung-Huei
|
|
|
7 |
12 |
p. 2897-2911
|
artikel
|
| 18 |
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
|
McNerney, Kevin O.
|
|
|
7 |
12 |
p. 2758-2771
|
artikel
|
| 19 |
Ilett EE, Jørgensen M, Noguera-Julian M, et al. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv. 2020;4(22):5797-5809.
|
|
|
|
7 |
12 |
p. 2677
|
artikel
|
| 20 |
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AML
|
Perriello, Vincenzo Maria
|
|
|
7 |
12 |
p. 2855-2871
|
artikel
|
| 21 |
Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
|
Ragon, Brittany Knick
|
|
|
7 |
12 |
p. 2746-2757
|
artikel
|
| 22 |
Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations
|
Shimonishi, Naruto
|
|
|
7 |
12 |
p. 2831-2842
|
artikel
|
| 23 |
Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.
|
|
|
|
7 |
12 |
p. 2925
|
artikel
|
| 24 |
More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura
|
Picod, Adrien
|
|
|
7 |
12 |
p. 2678-2680
|
artikel
|
| 25 |
Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL
|
Zurko, Joanna
|
|
|
7 |
12 |
p. 2657-2669
|
artikel
|
| 26 |
Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy
|
Lee, Brittany M.
|
|
|
7 |
12 |
p. 2825-2830
|
artikel
|
| 27 |
Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations
|
Andolfo, Immacolata
|
|
|
7 |
12 |
p. 2681-2693
|
artikel
|
| 28 |
Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome
|
Katzerke, Christiane
|
|
|
7 |
12 |
p. 2811-2824
|
artikel
|
| 29 |
Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report
|
Johnston, Emily E.
|
|
|
7 |
12 |
p. 2843-2854
|
artikel
|
| 30 |
Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
|
Petersdorf, Effie W.
|
|
|
7 |
12 |
p. 2888-2896
|
artikel
|
| 31 |
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
|
Allen, Pamela B.
|
|
|
7 |
12 |
p. 2670-2676
|
artikel
|
| 32 |
Unraveling the pathophysiology of lower-limb postthrombotic syndrome in adolescents: a proof-of-concept study
|
Avila, M. Laura
|
|
|
7 |
12 |
p. 2784-2793
|
artikel
|
| 33 |
Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993.
|
|
|
|
7 |
12 |
p. 2715-2717
|
artikel
|
| 34 |
Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells
|
Teh, Charis E.
|
|
|
7 |
12 |
p. 2733-2745
|
artikel
|
| 35 |
Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia
|
Tam, Constantine S.
|
|
|
7 |
12 |
p. 2884-2887
|
artikel
|
Tijdschrift beschrijving